Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to evaluate the safety and efficacy of clobetasol propionate spray versus vehicle spray for the management of moderate to severe plaque psoriasis of the scalp.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Galderma R&D
NCT05969223 · Genital Psoriasis, Scalp Psoriasis
NCT01195831 · Scalp Psoriasis
NCT01083758 · Scalp Psoriasis
NCT06015152 · Scalp Psoriasis
NCT00400725 · Scalp Psoriasis
Dermatology Research Associates
Los Angeles, California
Hudson Dermatology
Evansville, Indiana
Research Division of The Skin Specialty Group
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions